TTA1 Cells
US$ 395,00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Informações gerais
| Descrição | The TTA-1 cell line is derived from an undifferentiated thyroid carcinoma, also known as anaplastic thyroid carcinoma (ATC). This cell line exhibits the highly aggressive characteristics associated with ATC, including rapid proliferation and resistance to conventional therapies. Cytogenetic analysis of TTA-1 cells revealed extensive chromosomal abnormalities, with a modal chromosome number of 56-59 and numerous structural rearrangements. These features highlight the genetic instability typical of ATC. TTA-1 cells have been utilized extensively in research on tumorigenicity and oncogenesis. Studies have shown that tumorigenicity of TTA-1 cells can be modulated by genetic interventions, such as the introduction of chromosome 11 through microcell-mediated chromosome transfer. The addition of this chromosome led to partial suppression of tumorigenic properties, suggesting the presence of tumor suppressor genes on chromosome 11. Such studies provide insights into potential genetic therapeutic approaches to ATC. TTA-1 cells are known to secrete cytokines such as interleukin-6 (IL-6), which is implicated in cancer progression and the inflammatory responses associated with ATC. The production of cytokines by TTA-1 cells reflects their role in mediating tumor microenvironment interactions, making them a valuable model for studying both ATC biology and therapeutic resistance. |
|---|---|
| Organismo | Human |
| Tecido | Thyroid gland |
| Doença | Thyroid gland anaplastic carcinoma |
| Sinônimos | TTA1, TTA-I |
Características
| Idade | 64 years |
|---|---|
| Gênero | Male |
| Morfologia | Epithelial |
| Propriedades de crescimento | Adherent |
Dados regulatórios
| Referência | TTA1 (Cytion catalog number 305138) |
|---|---|
| Nível de biossegurança | 1 |
| NCBI_TaxID | 9606 |
| Número de acesso do Cellosaurus | CVCL_6297 |
Dados biomoleculares
| Tumorigênico | Yes |
|---|
Manuseio
| Meio de cultura | DMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 3.7 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a) |
|---|---|
| Suplementos | Supplement the medium with 10% FBS |
| Reagente de dissociação | Accutase |
| Tempo de duplicação | 28.8 hours |
| Subcultura | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Meio de congelamento | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Descongelamento e cultura de células |
|
| Atmosfera de incubação | 37°C, 5% CO2, humidified atmosphere. |
| Condições de envio | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Condições de armazenamento | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Controle de Qualidade e Análise Molecular
| Esterilidade | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|